Aurora Cannabis stock soars on Q3 results

If the pot stock trade is done, someone forget to tell Aurora Cannabis (Aurora Cannabis Stock Quote, Chart, News, Analysts, Financials TSX:ACB).

On February 5, ACB reported its Q3, 2025 results. The company posted Net Income of $31.2-million, which was a record, and up 282%, year-over-year.

ACB’s Net revenue, meanwhile was up 37%, year-over-year, to $88.2-million.

“This quarter was record-breaking for Aurora, driven by all-time highs in global medical net revenue1, net income, adjusted EBITDA1, and free cash flow,” CEO Miguel Martin said. “These achievements, along with our strong cash position and debt-free cannabis business, underscore Aurora’s leadership in the global cannabis industry as we continue to set ourselves apart from our peers,” said , Executive Chairman and Chief Executive Officer for Aurora Cannabis. Our strong top-line performance and record adjusted EBITDA1 were mostly fueled by contributions from our global medical cannabis business. International net revenue1 grew 112% and accounted for 60% of global medical cannabis net revenue1. Additionally, our plant propagation segment increased 22%, driven by organic expansion and an enhanced product portfolio, further strengthening our operating model. Our stated goals of continued strategic growth, operational excellence, and long-term sustained profitability are unwavering and we are deeply appreciative of our team’s efforts in helping us achieve these milestones.”

At press time shares of Aurora on the TSX were up 50.9% to $7.97.